Abstract
Human cell lines are often used to investigate cellular pathways relevant for physiological or pathological processes or to evaluate cell toxicity or protection induced by different compounds, including potential drugs. In this study, we analyzed and compared the differentiating activities of three agents (retinoic acid, staurosporine and 12-O-tetradecanoylphorbol-13-acetate) on the human neuroblastoma SH-SY5Y and BE(2)-M17 cell lines; the first cell line is largely used in the field of neuroscience, while the second is still poorly characterized. After evaluating their effects in terms of cell proliferation and morphology, we investigated their catecholaminergic properties by assessing the expression profiles of the major genes involved in catecholamine synthesis and storage and the cellular concentrations of the neurotransmitters dopamine and noradrenaline. Our results demonstrate that the two cell lines possess similar abilities to differentiate and acquire a neuron-like morphology. The most evident effects in SH-SY5Y cells were observed in the presence of staurosporine, while in BE(2)-M17 cells, retinoic acid induced the strongest effects. Undifferentiated SH-SY5Y and BE(2)-M17 cells are characterized by the production of both NA and DA, but their levels are considerably higher in BE(2)-M17 cells. Moreover, the NAergic phenotype appears to be more pronounced in SH-SY5Y cells, while BE(2)-M17 cells have a more prominent DAergic phenotype. Finally, the catecholamine concentration strongly increases upon differentiation induced by staurosporine in both cell lines. In conclusion, in this work the catecholaminergic phenotype of the human BE(2)-M17 cell line upon differentiation was characterized for the first time. Our data suggest that SH-SY5Y and BE(2)-M17 represent two alternative cell models for the neuroscience field.
Highlights
In the vertebrate central nervous system, catecholaminergic (CAergic) neurons constitute anatomically discrete groups of cells that synthesize and release the neurotransmitters dopamine (DA) and noradrenaline (NA)
Cellular models are instrumental for in vitro or ex vivo studies to analyze the cellular pathways that govern physiological or pathological processes or to evaluate the cell toxicity or protection induced by different compounds, including potential drugs
To provide one of these criteria, here we investigated the CAergic pathway of two human neuroblastoma cell lines: SH-SY5Y and BE(2)-M17
Summary
In the vertebrate central nervous system, catecholaminergic (CAergic) neurons constitute anatomically discrete groups of cells that synthesize and release the neurotransmitters dopamine (DA) and noradrenaline (NA). DAergic neurons, which originate in the ventral tegmental area, the substantia nigra and the hypothalamus, are involved in motor control, the control of emotional balance, reward-associated behavior, attention, and memory and the secretion of hormones such as prolactin [1] The majority of NA neurons are concentrated in the locus coeruleus and contribute to the regulation of arousal, sleep–wake patterns, sensory perception and emotional status [2, 3]. A malfunction in the mesocortical and mesolimbic DAergic pathways is linked to schizophrenia and the attention deficit, addiction, and hyperactivity disorders. Dysregulation of the NAergic system may result in deficits in a variety of cognitive and affective processes and is related to depression and sleep disorders
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
